Combined Metabolic Activators (CMAs) Improves Cognitive Functions in Alzheimer’s Disease

Results of a new phase 2 clinical study assessing whether administration of a mixture of Combined Metabolic Activators (CMAs) including NAD+ precursor nicotinamide riboside (NR) could treat Alzheim...

Increasing Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Reduced Neurodegeneration, and Increased Lifespan in Preclinical Model

The human body is composed of cells in the trillions. Each cell relies on a resource molecule called NAD+ for the generation of energy we know as ATP. This energy helps cells perform their unique f...

Two Experts Weigh In On Energy and Brain Health

Most of us are aware there are steps we can take to support the health of our hearts, teeth, eyes, and other vital organs. But when it comes to our brains, we’re often stumped.

NR Promotes Mitochondrial Health and Protects Against Alzheimer’s Disease in Multiple Preclinical Models

Alzheimer’s disease is a chronic condition in which a person’s cognitive functions, such as memory, language, and mood, decline with increasing age.